Paper35632575
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.
Facciolà A and 3 others. Vaccines (Basel), 2022. Cited by 231 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Papers, record 35632575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35632575
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References212
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 23,142,589 | Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. | Vaccine | 2012 | https://conductscience.org/library/papers/23142589 | PubMed |
| 3 | 16,043,410 | Revisiting Freund's incomplete adjuvant for vaccines in the developing world. | Trends Parasitol | 2005 | https://conductscience.org/library/papers/16043410 | PubMed |
| 4 | 18,650,390 | Molecular and cellular signatures of human vaccine adjuvants. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18650390 | PubMed |
| 5 | 32,971,761 | Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32971761 | PubMed |
| 6 | 20,844,205 | The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity. | J Immunol | 2010 | https://conductscience.org/library/papers/20844205 | PubMed |
| 7 | 32,318,915 | Vaccine confidence in the time of COVID-19. | Eur J Epidemiol | 2020 | https://conductscience.org/library/papers/32318915 | PubMed |
| 8 | 24,390,332 | Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. | J Virol | 2014 | https://conductscience.org/library/papers/24390332 | PubMed |
| 9 | 16,369,026 | A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. | Infect Immun | 2006 | https://conductscience.org/library/papers/16369026 | PubMed |
| 10 | 21,918,512 | The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. | Nature | 2011 | https://conductscience.org/library/papers/21918512 | PubMed |
| 11 | 28,985,943 | No evidence of DNA damage by co-exposure to extremely low frequency magnetic fields and aluminum on neuroblastoma cell lines. | Mutat Res Genet Toxicol Environ Mutagen | 2017 | https://conductscience.org/library/papers/28985943 | PubMed |
| 12 | 21,995,388 | Oil-in-water emulsion adjuvant with influenza vaccine in young children. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21995388 | PubMed |
| 13 | 22,065,672 | Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. | J Exp Med | 2011 | https://conductscience.org/library/papers/22065672 | PubMed |
| 14 | 32,188,383 | A Comprehensive Insight Towards Pharmaceutical Aspects of Graphene Nanosheets. | Curr Pharm Biotechnol | 2020 | https://conductscience.org/library/papers/32188383 | PubMed |
| 15 | 33,053,910 | Classical Examples of the Concept of the ASIA Syndrome. | Biomolecules | 2020 | https://conductscience.org/library/papers/33053910 | PubMed |
| 16 | 26,897,363 | The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models. | Parasit Vectors | 2016 | https://conductscience.org/library/papers/26897363 | PubMed |
| 17 | 25,692,975 | Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo. | Nat Commun | 2015 | https://conductscience.org/library/papers/25692975 | PubMed |
| 18 | 26,555,265 | Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26555265 | PubMed |
| 19 | 22,619,554 | Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22619554 | PubMed |
| 20 | 1,987,271 | Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. | J Immunol | 1991 | https://conductscience.org/library/papers/1987271 | PubMed |
| 21 | 21,697,806 | Ten great public health achievements--worldwide, 2001-2010. | MMWR Morb Mortal Wkly Rep | 2011 | https://conductscience.org/library/papers/21697806 | PubMed |
Cited by160
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,663,142 | Clinical and public health economic impact of rapid strain-matched vaccination in influenza pandemic mitigation: A UK-like population dynamic transmission model. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42663142 | PubMed |
| 42,654,751 | The Role of Adjuvant Nonavalent HPV Vaccination After LLETZ in Patients with Isolated CIN2: A Controlled Cohort Study. | Pathogens | 2026 | https://conductscience.org/library/papers/42654751 | PubMed |
| 42,654,300 | Dietary Aluminium Exposure and Human Health: Sources, Bioavailability, Toxicokinetics, and Health Risk Assessment. | Nutrients | 2026 | https://conductscience.org/library/papers/42654300 | PubMed |
| 42,613,385 | Proteome conserved multi-epitope-based vaccine construct against Nipah virus. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42613385 | PubMed |
| 42,598,270 | Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice. | Vaccine X | 2025 | https://conductscience.org/library/papers/42598270 | PubMed |
| 42,589,673 | Broad-Spectrum Multi-Epitope Design Targeting Conserved Hantavirus Glycoproteins (Gn/Gc): Chimeric Antigen Engineering and Structural Mapping. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589673 | PubMed |
| 42,541,679 | Immunoinformatics-driven multi-epitope vaccine design as a promising strategy against multidrug-resistant pathogens: a comprehensive review. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42541679 | PubMed |
| 42,459,443 | Assessment of Immunogenicity of Multi-Epitope DNA Vaccine Encoding CDPK3, ROP22 & MIC8 of Toxoplasma gondii Adjuvanted with IL-12 against Acute and Chronic Toxoplasmosis in BALB/c Mice. | Iran J Parasitol | 2026 | https://conductscience.org/library/papers/42459443 | PubMed |
| 42,455,409 | Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization. | Discov Nano | 2026 | https://conductscience.org/library/papers/42455409 | PubMed |
| 42,347,646 | Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347646 | PubMed |
| 42,347,631 | Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347631 | PubMed |
| 42,347,628 | Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347628 | PubMed |
| 42,344,914 | From Jenner to genomics: the unfolding future of vaccinology. | Front Immunol | 2026 | https://conductscience.org/library/papers/42344914 | PubMed |
| 42,340,354 | Salmonella-derived OMVs as a vaccine platform for Riemerella anatipestifer outer membrane proteins to prevent infection in ducks. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/42340354 | PubMed |
| 42,238,579 | An engineered intradermal microneedle-array device enhances the cellular immune responses in a guinea pig model. | Front Immunol | 2026 | https://conductscience.org/library/papers/42238579 | PubMed |
| 42,220,545 | Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220545 | PubMed |
| 42,196,252 | Vaccine Adjuvants and Delivery Systems: A Comprehensive Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196252 | PubMed |
| 42,176,436 | Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi. | Vaccine | 2026 | https://conductscience.org/library/papers/42176436 | PubMed |
| 42,129,077 | Proteomic Analysis of Influenza. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42129077 | PubMed |
| 42,075,186 | From Classical Bacterins to Recombinant Vaccines: Critical Aspects of the Immune Response in Ruminants. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075186 | PubMed |
Genes37
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35632575
GET https://conductscience.org/api/papers/v1/35632575/references?page=2